Hospital Clinico Universitario de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2020

  1. Clinical and Pathological Characterization of Lynch-Like Syndrome

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 368-374.e1

  2. Hereditary leiomyomatosis and renal cell cancer syndrome in spain: Clinical and genetic characterization

    Cancers, Vol. 12, Núm. 11, pp. 1-16

2019

  1. DNA Methylation of tumor suppressor genes in pituitary neuroendocrine tumors

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 4, pp. 1272-1282

  2. Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: Diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS)

    Hereditary Cancer in Clinical Practice, Vol. 17, Núm. 1

  3. miR302a and 122 are deregulated in small extracellular vesicles from ARPE-19 cells cultured with H2O2

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Performance of a quantitative pcrbased assay and beta-D-glucan detection for diagnosis of invasive candidiasis in very-low-birth-weight preterm neonatal patients (candineo study)

    Journal of Clinical Microbiology, Vol. 55, Núm. 9, pp. 2752-2764

2014

  1. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients

    European Journal of Cancer, Vol. 50, Núm. 13, pp. 2241-2250

2003

  1. Pseudomonas aeruginosa: Estudio multicéntrico en 136 hospitales Españoles

    Revista Espanola de Quimioterapia, Vol. 16, Núm. 1, pp. 41-52